FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Authority Hl7

31,787 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 3000 - 3200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.101.jsonAllergy or Intolerance to ARB Medicationactive2024-11ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.102.jsonChronic Kidney Disease Stage 1active2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.103.jsonChronic Kidney Disease Stage 2active2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.104.jsonChronic Kidney Disease Stage 3active2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.105.jsonChronic Kidney Disease Stage 4active2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.106.jsonChronic Kidney Disease Stage 5active2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.107.jsonICD10 CM Chronic Kidney Disease Stage 1active2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.108.jsonICD10 CM Chronic Kidney Disease Stage 2active2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.111.jsonAHA GWTG Chronic Kidney Disease Stage 2active2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.112.jsonICD10 CM Chronic Kidney Disease Stage 3active2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.113.jsonICD10 CM Chronic Kidney Disease Stage 4active2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.114.jsonICD10 CM Chronic Kidney Disease Stage 5active2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.115.jsonAHA GWTG Chronic Kidney Disease Stage 1active2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.116.jsonAHA GWTG Chronic Kidney Disease Stage 3active2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.117.jsonAHA GWTG Chronic Kidney Disease Stage 4active2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.118.jsonSNOMED CT Atrial Fibrillationactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.119.jsonICD10 CM Atrial Fibrillationactive2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.121.jsonAHA GWTG Atrial Fibrillationactive2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.123.jsonSNOMED CT Hyperlipidemiaactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.124.jsonICD10 CM Hyperlipidemiaactive2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.125.jsonAHA GWTG Hyperlipidemiaactive2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.126.jsonSNOMED CT Hypertriglyceridemiaactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.127.jsonICD10 CM Hypertriglyceridemiaactive2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.129.jsonAHA GWTG Hypertriglyceridemiaactive2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.130.jsonSNOMED CT Gestational Diabetesactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.131.jsonICD10 CM Gestational Diabetesactive2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.132.jsonAHA GWTG Gestational Diabetesactive2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.133.jsonSNOMED CT Hyperglycemiaactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.134.jsonICD10 CM Hyperglycemiaactive2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.135.jsonAHA GWTG Hyperglycemiaactive2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.136.jsonSNOMED CT Nonobstructive CADactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.137.jsonICD10 CM Nonobstructive Coronary Artery Diseaseactive2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.138.jsonAHA GWTG Nonobstructive coronary artery diseaseactive2024-11usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.139.jsonAHA GWTG Anti Obesity Pharmacotherapyactive2024-12usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.15.jsonNon Tobacco Smoking Product Useractive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.16.jsonAntihypertensive Fixed Dose Combination Medicationsactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.2.jsonPCSK9 Inhibitorsactive2023-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.20.jsonCCB and Thiazide and Thiazide Like Diureticsactive2021-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.21.jsonReferral to cardiac rehabactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.22.jsonCardiac Rehabilitationactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.25.json2 Hour Blood Glucose Testactive2022-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.26.jsonNYHA Functional Classificationactive2022-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.27.jsonARNI Therapyactive2022-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.29.jsonMRA Therapyactive2022-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.3.jsonCholesterol non HDL Laboratory Testactive2021-04usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.30.jsonSGLT2 Inhibitorsactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.31.jsonHeart Transplantactive2022-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.32.jsonHeart Transplantactive2022-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.33.jsonHeart Transplantactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.34.jsonAllergy to MRA Therapyactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.35.jsonAspirin or Clopidogrelactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.39.jsonCardiac Rehabilitationactive2024-01uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.4.jsonHypothyroidismactive2021-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.40.jsonCardiac Rehabilitationactive2022-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.43.jsonSGLT2 Ingredientsactive2022-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.44.jsonMRA Ingredientsactive2022-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.49.jsonMinnesota Living with Heart Failure Questionnaireactive2022-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.5.jsonHypothyroidismactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.50.jsonKansas City Cardiomyopathy Questionnaireactive2022-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.51.jsonCardiac Paceractive2021-11uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.52.jsonCardiac Paceractive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.53.jsonCardiac Paceractive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.54.jsonHeart Transplant Complicationsactive2022-03usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.55.jsonHeart Transplant Complicationsactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.56.jsonHeart Transplant Complicationsactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.57.jsonLeft Ventricular Assist Device Complicationsactive2022-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.58.jsonLeft Ventricular Assist Device Complicationsactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.59.jsonLeft Ventricular Assist Device Placementactive2023-02uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.6.jsonHypothyroidismactive2021-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.60.jsonLeft Ventricular Assist Device Placementactive2023-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.61.jsonLeft Ventricular Assist Device Placementactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.62.jsonLeft Ventricular Assist Device Placementactive2022-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.63.jsonHeart Transplantactive2022-07uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.65.jsonCardiac Paceractive2022-11uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.66.jsonDiastolic Heart Failureactive2023-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.67.jsonDiastolic Heart Failureactive2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.68.jsonDiastolic Heart Failureactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.69.jsonAllergy to SGLT2 Inhibitorsactive2023-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.7.jsonAnorexia Nervosaactive2023-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.70.jsonIntolerance to SGLT2 Inhibitorsactive2022-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.71.jsonIntolerance to MRA Therapyactive2022-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.72.jsonARNI Ingredientactive2022-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.73.jsonMitral Stenosisactive2022-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.74.jsonMitral Stenosisactive2022-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.75.jsonMitral Stenosisactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.76.jsonMechanical Prosthetic Heart Valveactive2022-11uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.77.jsonMechanical Prosthetic Heart Valveactive2025-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.78.jsonMechanical Prosthetic Heart Valveactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.79.jsonMechanical Prosthetic Heart Valve in Situactive2022-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.8.jsonAnorexia Nervosaactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.82.jsonSystolic Heart Failureactive2023-03usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.83.jsonSystolic Heart Failureactive2023-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.84.jsonSystolic Heart Failureactive2023-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.85.jsonCarotid Interventionactive2023-03uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.86.jsonSerum Creatinineactive2023-10usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.87.jsonUrine Creatinineactive2025-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.88.jsonUrine Albuminactive2023-10usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.9.jsonAnorexia Nervosaactive2021-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.90.jsonNon Steroidal Mineralcorticoid Receptor Antagonistactive2024-10usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.91.jsonGlucagon like peptide 1 medicationsactive2024-11usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.96.jsonAHA GWTG Long COVID19active2024-10usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.1.jsonWound internal item and/or body structure visible value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.11.jsonWound exudate appearance value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.12.jsonWound exudate color value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.13.jsonExudate odor value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.16.jsonSkin temperature value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.17.jsonSkin color enumerated value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.18.jsonSkin turgor value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.19.jsonSkin and mucous membrane integrity value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.2.jsonPeriwound condition value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.20.jsonSkin moisture value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.3.jsonWound Type Etiology value setactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.4.jsonWound episode value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.6.jsonWound bed appearance value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.60.jsonWound type reference setactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.7.jsonWound bed color value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.74.jsonNonverbal pain indicators reference setactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.76.jsonPain associated signs and symptoms reference setactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.77.jsonPain body location reference setactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.8.jsonWound edge description value set (foundation metadata concept)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.80.jsonPain quality reference setactive2025-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.81.jsonPain speed of onset reference setactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.9.jsonPresence absence value set (foundation metadata concept)active2018-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.1.jsonCommon drug substances for allergy and intolerance documentationactive2024-06usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.2.jsonCommon drug classes for allergy and intolerance documentationactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.3.jsonCommon dietary substances for allergy and intolerance documentationactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.4.jsonCommon environmental substances for allergy and intolerance documentationactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.10.jsonNHSNCriterionOfDiagnosisCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.11.jsonNHSNCriterionOfDiagnosisCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.12.jsonNHSNInfectionConditionCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.13.jsonNHSNInfectionConditionCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.14.jsonNHSNInfectionTypeCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.15.jsonNHSNInfectionTypeCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.16.jsonNHSNInfectionFirstReportedSource(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.17.jsonNHSNInfectionFirstReportedSource(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.18.jsonNHSNLOS/MENDischargeDisposition(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.19.jsonNHSNLOS/MENDischargeDisposition(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.20.jsonNHSNPopulationSummaryReportTypeCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.21.jsonNHSNPopulationSummaryReportTypeCode(LOINC)active2020-08usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.22.jsonNHSNSameDayOutcomeMeasure(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.23.jsonNHSNSameDayOutcomeMeasure(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.24.jsonNHSNSignificantPathogenCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.25.jsonNHSNSignificantPathogenCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.26.jsonNHSNSpinalFusionApproachCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.27.jsonNHSNSpinalFusionApproachCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.28.jsonNHSNVascularAccessTypeCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.29.jsonNHSNVascularAccessTypeCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.30.jsonNHSNVascularSpecimenCollectionSite(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.31.jsonNHSNVascularSpecimenCollectionSite(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.38.jsonBlood Glucose Laboratory and Point of Care Testsactive2023-09usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.6.jsonNHSNPathogenCodeAROactive2025-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.63.jsonBacterial and Fungal Blood Culture Testsactive2022-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.7.jsonNHSNRoleOfPerformerCode(CDCNHSN)active2020-08uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.74.jsonEnteral Medication Routeactive2022-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.75.jsonIntravenous Medication Routeactive2022-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.79.jsonFidaxomicin, Vancomycin, and Metronidazoleactive2022-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.8.jsonNHSNRoleOfPerformerCode(SNOMEDCT)active2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.85.jsonBaloxaviractive2023-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.86.jsonPeramiviractive2023-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.87.jsonZanamiviractive2023-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.88.jsonDigestive, Intramuscular, Intravenous Route of Administrationactive2023-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.9.jsonNHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)active2020-08usnucc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.90.jsonNHSN LTC AU Antimicrobial Agentsactive2024-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.91.jsonLong Term Care Discharge Dispositionactive2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.94.jsonNHSNNeurogenicBladderactive2025-03usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.95.jsonNHSNSpinalCordInjuryactive2025-03usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.147.jsonSCIP Major Surgical Procedureactive2019-06uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3483.jsonFinancial Insecurity Screening Assessments Questionsactive2023-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3484.jsonFood Insecurity Screening Assessments Questionsactive2023-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3485.jsonHealth Literacy Screening Assessments Questionsactive2024-12usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3486.jsonHomelessness Screening Assessments Questionsactive2023-08usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3487.jsonHousing Instability Screening Assessments Questionsactive2023-08usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3488.jsonLess Than High School Education Screening Assessments Questionsactive2023-07usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3519.jsonHealth Insurance Coverage Status Screening Assessments And Questionsactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3520.jsonInadequate Housing Screening Assessments And Questionsactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.393.jsonHypoglycemics Severe Hypoglycemiaactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.394.jsonHypoglycemics Treatment Medicationsactive2025-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.4448.jsonLidocaineactive2024-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.491.jsonMedium Dose ICS Formoterol Preparationsactive2021-09usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.495.jsonICS LABA LAMA Preparationsactive2021-09usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.788.jsonSocial Determinants of Health Conditionsactive2024-12usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.15.jsonGeneral Surgeryactive2020-04uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.17.jsonCoagulation Disorder Conditionsactive2020-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.19.jsonAnticoagulant Medicationsactive2025-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.20.jsonAnticoagulant Medications, Oralactive2024-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.21.jsonAnticoagulant Medications, Injectionactive2024-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.28.jsonActive Bleedingactive2020-11usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.29.jsonFall Risk Increasing Drugs (FRIDs)active2021-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.30.jsonFall Risk Factorsactive2021-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.32.jsonTotal Hip Arthroplasty Surgeryactive2021-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.33.jsonTotal Knee Arthroplasty Surgeryactive2021-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.46.jsonOpioid Medicationsactive2021-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.47.jsonImaging Related to VTEactive2023-01uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.48.jsonAnticoagulant Medicationactive2024-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.49.jsonVTE Diagnosesactive2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.50.jsonBisphosphonate Therapyactive2022-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.51.jsonVTE Symptomsactive2022-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.52.jsonOncology Critical Care Unitsactive2022-03uscdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.53.jsonProvider Typesactive2022-05ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.56.jsonFOBT_Labactive2024-07uscpt